Invasive Streptococcus Pneumoniae Infection Causing Cardioembolic Stroke: A Clinical Proximity to Austrian Syndrome
Nilesh H Pawar1, Oliver J Nickalls2, Keng Leong Tan3
1Department of General Medicine, Sengkang General Hospital, Sengkang Health, Singhealth, Singapore.
Abstract:
Streptococcus pneumoniae (S. pneumoniae) is a significant human bacterial pathogen and the major cause of pneumonia. In the post-antibiotic era, S. pneumoniae endocarditis is rare but carries a high risk of central nervous system (CNS) involvement. We present a case of invasive S. pneumoniae infection, which led to a cardioembolic stroke in a young man from septic emboli. Diagnosing a disseminated S. pneumoniae infection at an early stage is crucial and may improve patient outcomes.
Insights
Streptococcus pneumoniae infections can cause serious complications like stroke, even in young adults. Early diagnosis of invasive S. pneumoniae is vital for better patient outcomes in the post-antibiotic era.
Area of Science:
- Infectious Diseases
- Neurology
- Cardiology
Background:
- Streptococcus pneumoniae is a major cause of pneumonia.
- Invasive S. pneumoniae infections pose a high risk of central nervous system (CNS) involvement, particularly in the post-antibiotic era.
- Endocarditis caused by S. pneumoniae is rare but serious.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Endocarditis II: Clinical Features of Infective Endocarditis
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:


